Luxcel Biosciences provides drug discovery solutions, tools and assay systems to the pharmaceutical and related industries. The companys current products enable high throughput cell-based drug screening and related applications. Luxcel is working directly with major pharmaceutical companies and has a number of global distribution agreements in place.
The company achieved 100K of investment funding in 2004 following, according to the company's CEO spending between six months and a year getting its business plan as "strong as possible".
Luxcel has collborated with Queens University Belfast via a FUSION project with the Department of Immunology.
[edit]
Staff
- CEO Dr Richard Fernandes
[edit]


![[Main Page]](/modules/mediawiki/images/mediawiki.png)